On this page you’ll find the latest news about CataloniaBio & HealthTech and the member companies and knowledge stakeholders in the field of health and life sciences.
If you want to receive our news, please sign up for the monthly newsletter on our website or follow us on Twitter and LinkedIn with the hashtag #WeAreCataloniaBioHT.
1 June 2018
Banco Sabadell and Asabys Partners, founded by Josep Lluís Sanfeliu and Clara Campàs —member of the last Board of directors at CataloniaBio (2014-2018)—, have created a new venture capital fund of 60 million euros which will centre its investment activity in the health arena.
The new fund is known as Sabadell Asabys Health Innovation Fund. It will carry out initial investments in biotech, MedTech and digital health companies in Spain, as well as the UK and Israel.
The fund could obtain up to 6 million euros per company, and expects to work closely with research centres and benchmark ...
23 May 2018
Bionure, member of CataloniaBio & HealthTech that develops neuroprotectant agents to treat neurodegenerative diseases primarily focusing on rare ophthalmologic diseases as Acute Optic Neuritis (AON) and Neuromyelitis Optica (NMO), announces the initiation of a Phase I clinical trial of its lead compound BN201 in the United Kingdom.
BN201 is a first-in-class selective SGK2 agonist that promotes remyelination and neuroprotection, offering a game-changing solution for neurodegenerative diseases.
The company has reconstituted its Board of Directors and added prominent neuro-ophthalmologist Dr. Craig Smith as the new Chief Medical Officer (CMO). Dr Smith is a Senior Advisor/Consultant with the Bill and Melinda ...
16 May 2018
For five months, a total of eleven emerging companies will receive free training and guidance...
15 May 2018
Bicosome, a CataloniaBio & HealthTech member that has developed technology to...
15 May 2018
Kiversal, a CataloniaBio & HealthTech member, has been awarded a €182,000 grant from the 2017 Neotec programme...
8 May 2018
Mitelos, member of CataloniaBio & HealthTech, has signed a partnership agreement with Glenmark Pharmaceuticals Ltd to...
2 May 2018
The new location in the heart of city’s tech hub is situated in Canada’s largest biotech cluster...
2 May 2018
Spherium Biomed announced the completion of its Phase I/IIa clinical trial of Mucomel® for the prevention...
2 May 2018
Asphalion, scientific and regulatory affairs consultancy, has opened its third office in Madrid managed by Dr André Mota...
26 April 2018
Avinent has posted several research studies on its website that wereconducted in collaboration with renowned scientists and...
25 April 2018
Hartmann presented its latest advances in negative-pressure wound therapy (NPWT)...
25 April 2018
Compliance Services, a regulatory affairs consultancy for the health sector and member of CataloniaBio & HealthTech...
20 April 2018
Eleven Catalan companies from the 3D printing and medical devices sectors participated in a mission to Boston (Massachusetts, United States), from 16 to 19 April, organised by the Government of Catalonia (through ACCIÓ) and the Catalonia Trade and Investment Office in Boston, with collaboration from CataloniaBio & HealthTech.
Over the four-day mission, Avinent, Diopma, Mastertec, Neos Surgery, Servocad Microtronics, Tractivus and Ventura Medical, plus the Institute for Bioengineering of Catalonia (IBEC), Hospital Clinic, Althaia Foundation and Fira de Barcelona, met with companies and organisations including Massachusetts General Hospital, Tufts Medical Center, Boston Scientific, Weitz Laboratory at Harvard University and Johnson ...
18 April 2018
A delegation of eight Catalan companies from the biomedicine and health arena, most CataloniaBio & HealthTech members...
12 April 2018
Reig Jofre has announced a €30 million investment and the triplication of the productive capacity of its Barcelona plant...
11 April 2018
Palex Medical, a CataloniaBio & HealthTech member company, will be the exclusive distributor in Spain and...
11 April 2018
AB-Biotics, a CataloniaBio & HealthTech member company, has closed a deal with the Japan-based Kaneka...
10 April 2018
Vytrus Biotech, a CataloniaBio & HealthTech member company, has successfully closed the €1-million round...
6 April 2018
Devicare and nine leading hospitals in urology have started the pioneering international "Double J" study to...
6 April 2018
Grifols, member of CataloniaBio & HealthTech, makes inroads in its research efforts to find a treatment for Alzheimer...